Drug Profile
Research programme: phosphodiesterase 10 inhibitors - FORUM Pharmaceuticals
Alternative Names: EVX 001650; PDE10iLatest Information Update: 10 Apr 2014
Price :
$50
*
At a glance
- Originator EnVivo Pharmaceuticals
- Class
- Mechanism of Action Phosphodiesterase 10A inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Schizophrenia
Most Recent Events
- 02 Apr 2014 EnVivo Pharmaceuticals is now called FORUM Pharmaceuticals
- 07 Nov 2013 No development reported - Preclinical for Schizophrenia in USA (PO)
- 06 Dec 2011 Preclinical development is ongoing in USA